- Home
- / Aptose Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Aptose Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.4
2024-10-29
Market Capitalization
$7.1 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|
| General and administrative expense | 5.6M | 10.4M | 10.0M | 26.5M | 19.5M | 14.5M | 15.6M | 11.2M | 13.4M |
| Operating expense total | 11.8M | 29.1M | 26.9M | 55.8M | 65.4M | 42.6M | 26.3M | 24.7M | |
| Depreciation and amortization | 22.0K | ||||||||
| Interest income | 283.0K | 574.0K | 522.0K | 94.0K | 788.0K | 1.2M | 357.0K | 105.0K | |
| Pre tax profit | (21.8M) | (20.5M) | (39.8M) | (52.4M) | (36.6M) | (45.7M) | (21.6M) | (20.9M) | |
| Net Income | (11.7M) | (28.9M) | (26.3M) | (55.2M) | (65.4M) | (41.8M) | (51.2M) | (25.4M) | (25.5M) |
| EPS | (0.4) | (7.0) | (36.4) | (10.4) |